Varian Medical Systems (VAR) Misses Q1 EPS by 1c, Revenues Beat; Offers FY19 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Varian Reports Results for First Quarter of Fiscal Year 2019
January 23, 2019 4:06 PM ESTPALO ALTO, Calif., Jan. 23, 2019 /PRNewswire/ --
First Quarter 2019 Summary      Oncology gross orders grew 16% in dollars, or 17% in constant currency      Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million      GAAP operating earnings grew 11% at 18.2% of revenues; Non-GAAP operating earnings declined 5% at 16.2% of revenues      GAAP net earnings per diluted share of $1.12; Non-GAAP net earnings per diluted share of $1.06      Recently enacted US/China tariffs negatively impacted revenues by $8 million and operating earnings by $11 million, generally in line with company expectations      Reaffirming fiscal year 2019 guidance of Non-GAAP net earnings... More
